Hints and tips:
...capitalised much of Rosewood’s development....
...Sleath, a vegetarian, fitness-obsessed triathlete, is no archetypal property boss....
...That investment makes it unlikely that Apple’s first headset will do to the Quest what the iPhone did to the BlackBerry anytime soon....
...Get in touch with us anytime: Due.Diligence@ft.com. It’s not about who you know....
...Unite the union just managed to negotiate a cost of living increase for some groups of staff at Barclays that’s worth about, you know, 5 per cent consolidated....
...The venture capital group Anthemis has appointed two former Barclays executives to leadership positions: Mei Lim as chief financial officer and head of corporate development, and Harry Harrison as vice-chair...
...Get in touch with us anytime: Due.Diligence@ft.com....
...Letter in response to this article: Fischer looked such a nice kid as he laid his traps / From William Hamilton, Phoenix, AZ, US...
...Investors have taken some comfort from developments in the oil market, where major producers proposed freezing output at January’s level in an effort to ease a supply glut and shore up prices....
...To help it fend off the competition, Fitbit doubled its research and development spend last year to $54m....
...Google Fit is designed to draw data from devices running the Android operating system and integrate with apps from other companies that collect fitness or health data....
...But this month the California company went a step further in making its own push into drug development by hiring Richard Scheller, former head of research and development at Genentech, the biotech arm of...
...“I’ll not be on The Apprentice anytime soon but it’s been a groovy little story so far.”...
...Most of the accessible space, however, is given over to lawn, on which there are deckchairs, occasional yoga and fitness classes, and a large central fire pit for cool evenings....
...We expect that we will continue to incur research and development, marketing and other costs to launch new services and grow our user and advertiser bases....
...Drug development is getting harder and more expensive. Moreover, AZ faces the biggest patent cliff of any of its peers....
...He said the deal built on AstraZeneca’s £702m acquisition last year of CAT, reinforcing the range of technologies and products in development by providing MedImmune’s manufacturing and marketing capacity...
...The ratings changes came before Barratt Developments, up 1.1 per cent at 608p, announced it had appointed UBS as one of its joint brokers....
International Edition